MDA Facts
Psychedelic;
Description
MDA (3,4-methylenedioxyamphetamine) — Sass, Sally, Love Drug — is a synthetic empathogen of the substituted amphetamine class. MDA floods serotonin, dopamine, and norepinephrine into the brain while also directly activating serotonin receptors — the same ones classical psychedelics target.[1]
Subjective effects include empathogenic warmth, emotional openness, stimulation, wakefulness, and genuine closed-eye hallucinations — geometry, formed imagery, and complex scenes.[2] The experience layers psychedelic depth over MDMA-like closeness, with stronger stimulation than either — a combination that sets MDA apart from pure empathogens and classical psychedelics alike.[3]
MDA does not produce physical dependence, but it is more neurotoxic than MDMA — the liver converts it into compounds that selectively destroy serotonin nerve terminals.[4][5] Heat amplifies this damage sharply: even small temperature increases make neurotoxicity substantially worse,[6] making hot environments the most dangerous context.
Dose and durationby route · individual sensitivity varies
Starts in 30 – 60 minLasts 5 – 8 hoursAfter-effects 2 – 6 hours
Body and dependence
- Acute toxicity
- Moderate
- Chronic toxicity
- Moderate
- Physical dependence
- Negligible
- Psychological dependence
- Low
- Withdrawal
- None recorded
- Compulsive redosing
- Low
Tolerance
- Builds
- Rapid
- Fully resets after
- 7 days
- Carries over to
- MDMA;
serotonergic psychedelics; amphetamines
Effectslikely at a common dose
- Perception
- none likely · 21 possible, including Visual haze / noise, Spatial disorientation
- Body
- Stimulation;
Wakefulness; Appetite suppression; Pupil dilation; Insomnia; +23 possible, including Excessive sweating, Dehydration sensation, Temperature dysregulation - Thinking
- none likely · 20 possible, including Compulsive redosing urge, Cognitive impairment, Decision impairment
- Feeling
- Empathy enhancement;
Emotional enhancement; Euphoria; +7 possible, including Depression, Anhedonia, Emotional lability - Self
- none likely · 9 possible, including Derealization, Craving
- Transpersonal
- none likely · 1 possible
- Awareness
- none likely · 2 possible
Who shouldn't take it
Combinations61 recorded
Seek help immediately if
- Overheating / very high body temperature — heavy sweating, then hot dry skin (the leading cause of MDMA deaths, worse when dancing in hot venues)
- Muscle rigidity, jaw clenching, tremor, or twitching (possible serotonin syndrome)
- Fast, pounding heartbeat; chest pain
- Agitation, confusion; seizures
- Hyponatremia (water intoxication) — headache, confusion, drowsiness, vomiting, and seizures from drinking too much water
- Nausea/vomiting; collapse or unconsciousness
What to do
- Move them somewhere cool and help them cool down — overheating is the main danger
- Sip water to stay hydrated but DO NOT overdrink — roughly a cup (250 ml) per hour if active; too much water can be deadly (hyponatremia)
- Get them to rest and stop dancing
- For overheating, seizures, chest pain, muscle rigidity/tremor, confusion, or unresponsiveness, call emergency services
- Recovery position if drowsy or vomiting; stay with them
- Be ready to give rescue breaths / CPR
Most resolve with cooling, rest, sensible hydration, and time. The life-threatening dangers are hyperthermia, serotonin syndrome, and hyponatremia (too much water) — each a medical emergency, not something to wait out.
988 Suicide & Crisis LifelineFireside Project: 62-FIRESIDE
References
- [1]^Kolaczynska KE, Ducret P, Trachsel D, Hoener MC, Liechti ME, Luethi D (2022) Pharmacological characterization of 3,4-methylenedioxyamphetamine (MDA) analogs and two amphetamine-based compounds: N,α-DEPEA and DPIA — European Neuropsychopharmacology doi:10.1016/j.euroneuro.2022.03.006
- [2]^Baggott MJ, Siegrist JD, Galloway GP, Robertson LC, Coyle JR, Mendelson JE (2010) Investigating the mechanisms of hallucinogen-induced visions using 3,4-methylenedioxyamphetamine (MDA): a randomized controlled trial in humans — PLoS ONE doi:10.1371/journal.pone.0014074
- [3]^Straumann I, Vizeli P, Avedisian I, et al. (2026) Acute effects of MDMA, MDA, lysine-MDMA, and lysine-MDA in a randomized, double-blind, placebo-controlled, crossover trial in healthy participants — Neuropsychopharmacology doi:10.1038/s41386-025-02248-3
- [4]
- [5]^Monks TJ, Jones DC, Bai F, Lau SS (2004) The role of metabolism in 3,4-(+)-methylenedioxyamphetamine and 3,4-(+)-methylenedioxymethamphetamine (ecstasy) toxicity — Therapeutic Drug Monitoring PMID:15228153
- [6]^Malberg JE, Seiden LS (1998) Small Changes in Ambient Temperature Cause Large Changes in 3,4-Methylenedioxymethamphetamine (MDMA)-Induced Serotonin Neurotoxicity and Core Body Temperature in the Rat — Journal of Neuroscience doi:10.1523/jneurosci.18-13-05086.1998